Physician profile
Rachel Rome
NPI 1679795256
$733.36
in general payments reported to CMS, 2019-2025
18 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $320 · 2021: $55.75 · 2024: $250 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $357.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $166.43 | 2019-2024 | Wavewriter Alpha Prime 16 |
| Lilly USA, LLC | $84.76 | 2019 | |
| Mdd US Operations, LLC | $66.41 | 2019 | |
| Lundbeck LLC | $59.45 | 2024 | Vyepti |
| Organogenesis INC. | $55.75 | 2021 | |
| Collegium Pharmaceutical, INC. | $51.73 | 2019-2024 | Belbuca |
| Ibsa Pharma INC. | $48.29 | 2024 | Licart, Tirosint |
| Protega Pharmaceutials INC | $24.11 | 2025 | Roxybond |
| Abbott Laboratories | $23.78 | 2024 | Eterna |
| Insulet Corporation | $23.46 | 2025 | Omnipod |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.76 | 2025 | Relistor |
| Alkermes, INC. | $20.47 | 2025 | Vivitrol |
| Amgen INC. | $17.01 | 2025 | Evenity |
| Nevro Corp. | $16.80 | 2024 | Senza |
| Orthogenrx INC. | $15.51 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $14.10 | 2019 | |
| Sanofi-Aventis U.S. LLC | $11.58 | 2019 | |
| Pfizer INC. | $10.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Rome listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.